Kiora Pharmaceuticals, Inc. (KPRX) stock rallied over 0.66% intraday to trade at $0.152 a share on NASDAQ. The stock opened with a loss of -5.00% at $0.155 and touched an intraday high of $0.16, rising 0.66% against the last close of $0.151. The stock went to a low of $0.151 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) stock price is $0.152 as of the last check on Monday, August 8. During the trading session, KPRX stock reached the peak price of $0.16 while $0.151 was the lowest point it dropped to.
The NASDAQ listed KPRX is part of Pharmaceuticals industry that operates in the broader Health Care sector. Kiora Pharmaceuticals, Inc. , a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States.
Mr. Stephen From
Ms. Sarah Romano
Chief Financial Officer
Dr. Franz Obermayr Ph.D.
Exec. VP of Clinical Devel. & MD
Dr. Brian M. Strem Ph.D.
Pres, CEO & Director
KPRX stock traded closed the last session at $0.151, which is $0.0010000000000000009 or 0.6622516556291397% lower than its previous close of $0.151. KPRX's current trading price is 7.86% lower than its 52-week high of $2.35 where as its distance from 52-week low of 0.14% is -93.57%.
Number of KPRX employees currently stands at -. KPRX operates from 1371 East 2100 South, Suite 200, Salt Lake City, UT 84105, United States.
Official Webiste of $KPRX is: https://www.kiorapharma.com
KPRX stock volume for the day was 59,726 shares while in the previous session number of KPRX shares traded was 2,375,467 . The average number of KPRX shares traded daily for last 3 months was 889.18 Thousands.
The percentage change in KPRX stock occurred in the recent session was 0.6622516556291397% while the dollar amount for the price change in KPRX stock was $0.0010000000000000009.
In the recent session, the day high for KPRX stock was $0.16 while the low for KPRX stock touched on the day was $0.151.
The market value of KPRX currently stands at 2.11 Million with its latest stock price at $0.152 and 13.06 Million of its shares outstanding.